JPRN-UMIN000024821招募中未知
Acute effects of the sodium glucose transporter (SGLT) -2 inhibitors,Dapagliflozin, on Hemorheology,Leukocyte Activation and Oxidative Stress in type 2 diabetes. - Acute effects of the sodium glucose transporter (SGLT) -2 inhibitors on Hemorheology in type 2 diabetes
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(a) Patients with type 1 diabetes mellitus (b) Patients with a medical history of hypersensitivity to any of the ingredients of dapagliflozin (c) Patients with severe ketosis or diabetic coma or pre-coma (d) Patients who have severe infection, are pre- or postoperative, or have sustained serious trauma (e) Patients with severe impaired liver function (f) Patients who are susceptible to dehydration (g) Patients with urinary tract infection or genital infection (h) Patients with a history of cerebrovascular disease within the last 3 months (i) Women who are pregnant or breastfeeding or who may be pregnant (j) Estimated glomerular filtration rate (eGFR) <45 mL/min/1.73 mL (k) Patients on warfarin or a novel oral anticoagulant (NOAC) (dabigatran, rivaroxaban, edoxaban, or apixaban) (l) Patients otherwise deemed to be unsuitable for the clinical study by investigators
研究者
相似试验
进行中（未招募）
1 期
Sodium-glucose cotransporter-2 inhibition and renal oxygenation in type 1 diabetesMedDRA version: 21.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Type 1 diabetesEUCTR2019-004557-92-DKSteno Diabetes Center Copenhagen30
已完成
不适用
Effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000018367Ise Red Cross Hospital Department of Metabolic Diseases30
招募中
不适用
Pleiotropic Effects of Sodium glucose co-transporter 2 inhibitor on sympathetic nerve activity and organ network in patients with Type 2 diabetesType2 diabetes patients with multiple atherosclerosis risk factorsType2 diabetesD003924JPRN-jRCTs041200035TAKAMURA Toshinari40
尚未招募
Unknown
The effects Of sodium-glucose coTransporter 2 inhibiTOR on fastIng Hepatic Insulin Clearance in type 2 diabetesJPRN-jRCT1061230070Okura Tsuyoshi20
招募中
不适用
Impact of sodium-glucose transportation protein 2 inhibitor therapy on Diastolic hEart function and left AtriaL pressure in Atrial FibrillatioDiseases of the circulatory systemKCT0005166Asan Medical Center120